EDITORIAL
Published on 11 Mar 2020
Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
doi 10.3389/fphar.2020.00312
- 2,796 views
- 10 citations
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer Diseases and Acute and Chronic Pain
The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer Diseases and Acute and Chronic Pain
12k
Total downloads
69k
Total views and downloads
Articles
PERSPECTIVE
Published on 31 May 2019
Antitumor Cannabinoid Chemotypes: Structural Insights
doi 10.3389/fphar.2019.00621
- 10,330 views
- 30 citations
REVIEW
Published on 09 May 2019
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
doi 10.3389/fphar.2019.00430
- 11,800 views
- 65 citations
ORIGINAL RESEARCH
Published on 16 Apr 2019
Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury
doi 10.3389/fphar.2019.00352
- 11,501 views
- 56 citations
REVIEW
Published on 05 Apr 2019
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
doi 10.3389/fphar.2019.00339
- 27,659 views
- 106 citations
ORIGINAL RESEARCH
Published on 18 Dec 2018
Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury
doi 10.3389/fphar.2018.01481
- 3,005 views
- 12 citations
